ReNAgade Therapeutics Management Inc.

États‑Unis d’Amérique

 
Quantité totale PI 35
Rang # Quantité totale PI 40 447
Note d'activité PI 2,6/5.0    52
Rang # Activité PI 14 024
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

10 7
3 0
15 0
0
 
Dernier brevet 2024 - Lipid nanoparticles comprising c...
Premier brevet 2022 - Lipid nanoparticles and methods ...
Dernière marque 2023 - RNGD
Première marque 2022 - RENAGADE THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and t...
Invention Gene editing systems and compositions for treatment of hemoglobinopathies and methods of using th...
Invention Delivery of gene editing systems and methods of use thereof. The present disclosure describes imp...
Invention Compositions and methods for optimizing tropism of delivery systems for rna. The present disclos...
2023 Invention Lipid nanoparticles and methods of use thereof. The present disclosure provides pharmaceutical c...
P/S Biochemical preparations for scientific purposes; Biochemicals for use in the manufacture of RNA ...
P/S Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticl...
Invention Gene editing components, systems, and methods of use. The present disclosure provides methods an...
P/S Chemical and biological agents for scientific and research use, namely, for the modification of s...
Invention Engineered retrons and methods of use. Disclosed are engineered retrons and methods of use such a...
P/S Chemical and biological agents for scientific and research use, namely, for manipulating or modif...
Invention Pegylated lipid compounds and methods of use thereof. The present disclosure relates to PEGylated...
Invention Engineered retrons and methods of use. in vitroin vivoe.g.e.g., mammalian) cell.
Invention Constrained lipids and methods of use thereof. The present disclosure details various lipids, co...
Invention Gene editing components, systems, and methods of use. The present disclosure provides methods and...
Invention Cyclic lipids and methods of use thereof. The present disclosure details various lipids, composi...
Invention Nucleobase editing system and method of using same for modifying nucleic acid sequences. The disc...
Invention Cyclic lipids and lipid nanoparticles (lnp) for the delivery of nucleic acids or peptides for use...
2022 Invention Constrained lipids and methods of use thereof. The present disclosure details various lipids, com...
Invention Cyclic lipids and methods of use thereof. The present disclosure details various lipids, composit...
Invention Acyclic lipids and methods of use thereof. The present disclosure details various lipids, compos...
P/S Biochemicals, namely, protein-encoding nucleic acids in the nature of double-stranded and single-...
Invention Acyclic lipids and methods of use thereof. The present disclosure details various lipids, composi...
Invention Compositions and methods for optimizing tropism of delivery systems for rna. The present disclosu...
Invention Lipid nanoparticles and methods of use thereof. The present disclosure provides pharmaceutical co...